Zgura, A.; Chipuc, S.; Bacalbasa, N.; Haineala, B.; Rodica, A.; Sebastian, V.
Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review. Cancers 2025, 17, 480.
https://doi.org/10.3390/cancers17030480
AMA Style
Zgura A, Chipuc S, Bacalbasa N, Haineala B, Rodica A, Sebastian V.
Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review. Cancers. 2025; 17(3):480.
https://doi.org/10.3390/cancers17030480
Chicago/Turabian Style
Zgura, Anca, Stefania Chipuc, Nicolae Bacalbasa, Bogdan Haineala, Anghel Rodica, and Vâlcea Sebastian.
2025. "Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review" Cancers 17, no. 3: 480.
https://doi.org/10.3390/cancers17030480
APA Style
Zgura, A., Chipuc, S., Bacalbasa, N., Haineala, B., Rodica, A., & Sebastian, V.
(2025). Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review. Cancers, 17(3), 480.
https://doi.org/10.3390/cancers17030480